HeartSciences Faces Nasdaq Delisting After Equity Shortfall
HSCS sits 24% above its 52-week low of $1.63 on light trading volume (0.1× avg).
Summary
HeartSciences received a Nasdaq delisting notice after failing the $2.5M equity requirement. The company intends to lean on its pending merger with Fortitude Mining to regain compliance, but failure would likely trigger delisting.
Key Events · Legal and Risk Events · HSCS
-
Nasdaq Delisting Notice Received
On August 4, 2026, HeartSciences received a Nasdaq deficiency notice for failing to maintain the minimum $2.5 million stockholders' equity requirement, reporting only $226,060 in its latest 10-K.
-
Compliance Plan Deadline
The company has until September 18, 2026, to submit a plan to regain compliance. If accepted, Nasdaq may grant up to 180 days (until January 31, 2027) to evidence compliance.
-
Merger as Compliance Strategy
HeartSciences intends to use the pending all-stock merger with Fortitude Mining Holdings as the basis for its compliance plan, making the merger critical to maintaining its Nasdaq listing.
-
Delisting Risk Amplifies Existing Distress
The delisting notice compounds existing risks: a going-concern warning, material weaknesses in internal controls, and stockholders' equity of just $0.2 million. Failure to complete the merger or regain compliance could force the stock off Nasdaq.
Analysis · HSCS · Crypto Assets
A Nasdaq delisting notice has landed on HeartSciences because its stockholders' equity of $226,060 sits far below the required $2.5 million minimum. The company now has 45 days to submit a compliance plan, which hinges entirely on the pending all-stock merger with Fortitude Mining. Should the plan be rejected or the merger collapse, delisting becomes a near certainty—a severe blow for a firm already wrestling with a going-concern warning and material weaknesses. In effect, the merger has transformed from a strategic pivot into an existential necessity for preserving the Nasdaq listing.
How filings like this one have moved
In the 30 days to Oct 16, 2026, 44.9% of the 303 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.26%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HSCS was trading at $2.02 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $7.9M. The 52-week trading range was $1.63 to $3.93. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.